Episode 32: All About Afrezza

A Type 2 and the CEO of Mannkind Corp. Discuss How Inhalable Insulin Can Be Used to Manage Diabetes

Featured Guests

Michael Castagna, PharmD, Mannkind Corporation CEO, Joel Friedman, MD, a patient living with type 2 diabetes

Afrezza is the only rapid-acting insulin that is inhaled instead of injected. Learn more about the benefits and challenges of this unique form of insulin from a type 2 who uses it and the CEO of Mankind Corp. who helped develop it.

Moderator

Ann Matturro Gault, Editor of OnTrack Diabetes and Host of The Diabetes Dish Podcast

PLAY PODCAST

Diabetes is a serious disease requiring professional medical attention. The information and recipes on this site, although as accurate and timely as feasibly possible, should not be considered as medical advice, nor as a substitute for the same. All recipes and menus are provided with the implied understanding that directions for exchange sizes will be strictly adhered to, and that blood glucose levels can be affected by not following individualized dietary guidelines as directed by your physician and/or healthcare team.

MAIN MENU

Type 1 Diabetes

Prediabetes

Type 2 Diabetes

Live Well

Episode 32: All About Afrezza

A Type 2 and the CEO of Mannkind Corp. Discuss How Inhalable Insulin Can Be Used to Manage Diabetes

Keep in Touch!

Inspirational Stories

Don't Miss Out!